AKOYA BIOSCIENCES INC. - COMMON STOCK

Akoya Reports Record Revenue in the Fourth Quarter of 2022 and Provides Full Year 2023 Revenue Guidance

06 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences Announces Appointment of Jennifer Kamocsay as General Counsel

28 Feb 2023 07:00:02 By Nasdaq GlobeNewswire

Akoya to Report Fourth Quarter and Full Year 2022 Financial Results on March 6th, 2023 and Participate at Two Upcoming Investor Conferences

06 Feb 2023 07:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting

01 Feb 2023 07:00:01 By Nasdaq GlobeNewswire

Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2022

08 Jan 2023 15:00:00 By Nasdaq GlobeNewswire

Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference

28 Dec 2022 15:00:00 By Nasdaq GlobeNewswire

Akoya Biosciences Showcases Latest Spatial Biology Innovations at Virtual Spatial Day

15 Dec 2022 15:00:00 By Nasdaq GlobeNewswire

Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance

07 Nov 2022 15:05:01 By Nasdaq GlobeNewswire

Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy

07 Nov 2022 15:05:01 By Nasdaq GlobeNewswire

Akoya to Participate at Three Upcoming Investor Conferences

03 Nov 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya to Report Third Quarter 2022 Financial Results on November 7th, 2022

11 Oct 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya to Participate at Four Upcoming Investor Conferences

31 Aug 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Reports Second Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance

08 Aug 2022 15:05:01 By Nasdaq GlobeNewswire

Akoya to Participate at Two Upcoming Investor Conferences

27 Jul 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya to Report Second Quarter 2022 Financial Results on August 8th, 2022

12 Jul 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic

28 Jun 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences to Highlight Novel Spatial Transcriptomics Capabilities on PhenoCycler-Fusion at AGBT 2022 Annual Meeting

01 Jun 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Reports First Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance

05 May 2022 15:05:03 By Nasdaq GlobeNewswire

Akoya to Participate at Three Upcoming Investor Conferences

03 May 2022 07:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences Announces Ehab A. El-Gabry, MD, as Chief Medical Officer

19 Apr 2022 07:05:00 By Nasdaq GlobeNewswire